乳房切片市场规模、份额、成长分析、按产品、按适应症、按最终用户、按地区 - 行业预测，2024-2031 年

2022年全球乳房切片市场规模将为8.421亿美元，预测期间（2024-2031年）复合年增长率为8.2%，从2023年的9.1115亿美元增长到2031年的17.1163亿美元。

由于乳癌发病率上升以及人们对早期检测重要性的认识不断增强，全球乳房切片市场正在显着增长。推动这种扩张的关键因素包括对微创手术的日益偏好以及诊断影像和切片检查技术的技术进步。市场上有多种切片检查技术，包括粗针切片、辅助抽吸和细针抽吸，随着影像导引切片检查以提高准确性的趋势不断增长。自动化系统和手持工具等切片检查设备的创新正在提高手术效率和患者舒适度。虽然北美因其高乳癌发病率和强大的医疗基础设施而引领市场，但亚太和拉丁美洲的新兴国家准备投资更好的医疗保健，并提高乳癌筛检意识，预计将快速成长。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析

乳房切片市场规模：依产品及复合年增长率（2024-2031）

• 市场概况
• 切片穿刺针
  • 粗针切片
  • 细针吸引针
• MRI导引切片检查系统
• 超音波引导乳房切片系统
  • 二维乳房X光摄影超音波扫描系统
  • 3D B型乳房X光摄影超音波扫描系统
• 吸引辅助装置
• 导管导引线
• 乳房切片标记物

乳房切片市场规模：按适应症和复合年增长率（2024-2031）

• 市场概况
• 复杂囊肿
• 固态物质
• 可疑固态物质
• 可疑的微钙化

乳房切片市场规模：按最终用户和复合年增长率（2024-2031）

• 市场概况
• 医院
• 专科诊所
• 癌症研究所

乳房切片市场规模：按地区和复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Hologic, Inc.（USA）
• Danaher Corporation（USA）
• Becton, Dickinson and Company（BD）（USA）
• Argon Medical Devices（USA）
• Merit Medical Systems（USA）
• Menarini-Silicon Biosystems（Italy）
• Guardant Health, Inc.（USA）
• NeoGenomics（USA）
• Sysmex Inostics（Germany）
• Ethicon Endo-Surgery, Inc.（USA）
• CR Bard, Inc.（USA）
• Leica Biosystems Nussloch GmbH（Germany）
• Encapsule Medical Devices LLC（USA）
• Intact Medical Corporation（USA）
• Galini SRL（Italy）
• Cook Medical Incorporated（USA）
• Medtronic plc（Ireland）
• Devicor Medical Products, Inc.（USA）
• Carestream Health, Inc.（USA）
• Planmed Oy（Finland）

结论和建议

Global Breast Biopsy Market size was valued at USD 842.1 million in 2022 and is poised to grow from USD 911.15 million in 2023 to USD 1711.63 million by 2031, growing at a CAGR of 8.2% during the forecast period (2024-2031).

The global breast biopsy market is experiencing significant growth, driven by rising breast cancer incidence and increased awareness of the importance of early detection. Key factors fueling this expansion include technological advancements in imaging and biopsy techniques, alongside a growing preference for minimally invasive procedures. The market features a variety of biopsy methods, including core needle, vacuum-assisted, and fine needle aspiration, with an increasing trend toward image-guided biopsies for enhanced accuracy. Innovations in biopsy devices, such as automated systems and handheld tools, are improving procedural efficiency and patient comfort. While North America leads the market due to high breast cancer prevalence and robust healthcare infrastructure, emerging economies in Asia-Pacific and Latin America are anticipated to grow rapidly, propelled by better healthcare investment and heightened awareness of breast cancer screening.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Breast Biopsy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Breast Biopsy Market Segmental Analysis

Global Breast Biopsy Market is segmented by product, indication, end user and region. Based on product, the market is segmented into biopsy needles, MRI guide biopsy systems, ultrasound guided breast biopsy system, vacuum assisted devices, guide wire and breast biopsy markers. Based on indication, the market is segmented into complex cysts, solid mass, suspicious solid mass and suspicious micro calcifications. Based on end user, the market is segmented into hospitals, specialty clinics and cancer research institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Breast Biopsy Market

A primary factor propelling the Global Breast Biopsy Market is the rising incidence of breast cancer across the globe. As one of the most frequently diagnosed cancers, breast cancer's prevalence has been on the upswing, amplifying the need for effective early detection and intervention strategies. This increasing cancer burden has heightened the focus on accurate diagnosis, leading to a surge in demand for breast biopsy procedures. Consequently, the necessity for reliable diagnostic methods to identify breast irregularities and facilitate prompt treatment has significantly spurred growth in the breast biopsy market, reflecting a critical aspect of contemporary healthcare advancements.

Restraints in the Global Breast Biopsy Market

One significant limitation affecting the Global Breast Biopsy Market is the risk of false-negative and false-positive results. Although breast biopsies are essential for accurate breast cancer diagnosis, there is a chance that these procedures might yield incorrect findings. False-negative results may arise when cancerous cells are not identified, resulting in delayed diagnoses or overlooked cases. Conversely, false-positive results can prompt unnecessary anxiety, leading to additional tests or invasive procedures for patients. These issues surrounding diagnostic accuracy can diminish trust in the reliability of breast biopsies, complicating the decision-making process for both healthcare providers and patients when determining appropriate treatment strategies.

Market Trends of the Global Breast Biopsy Market

A notable trend in the global breast biopsy market is the rising preference for image-guided biopsy techniques, including ultrasound, mammography, and MRI-guided biopsies. These advanced methods have gained traction due to their enhanced ability to precisely locate and sample suspicious breast lesions, thereby increasing diagnostic accuracy and minimizing invasiveness compared to traditional approaches. Real-time imaging allows for superior visualization, leading to higher diagnostic yields and reducing the likelihood of repeat procedures. This shift towards image-guided biopsies underscores the industry's commitment to improving the accuracy and efficiency of breast biopsy protocols, while also emphasizing patient comfort and minimizing procedural risks. As a result, this trend is poised to shape future developments in breast cancer diagnostics and intervention.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Breast Biopsy Market Size by Product & CAGR (2024-2031)

• Market Overview
• Biopsy Needles
  • Core Needles
  • Fine Aspiration Needles
• Mri Guide Biopsy Systems
• Ultrasound Guided Breast Biopsy System
  • 2D Mammographic Ultrasonic Scanning Systems
  • 3D B-Mode Mammographic Ultrasonic Scanning Systems
• Vacuum Assisted Devices
• Guide Wire
• Breast Biopsy Markers

Global Breast Biopsy Market Size by Indication & CAGR (2024-2031)

• Market Overview
• Complex Cysts
• Solid Mass
• Suspicious Solid Mass
• Suspicious Micro Calcifications

Global Breast Biopsy Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals
• Specialty Clinics
• Cancer Research Institutes

Global Breast Biopsy Market Size & CAGR (2024-2031)

• North America (Product, Indication, End User)
  • USA
  • Canada
• Europe (Product, Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Indication, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Argon Medical Devices (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menarini-Silicon Biosystems (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guardant Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeoGenomics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Inostics (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ethicon Endo-Surgery, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C. R. Bard, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leica Biosystems Nussloch GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Encapsule Medical Devices LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intact Medical Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galini SRL (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Devicor Medical Products, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carestream Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Planmed Oy (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations